MicroRNA-497 targets hepatoma-derived growth factor and suppresses human prostate cancer cell motility.
Mol Med Rep
; 13(3): 2287-92, 2016 Mar.
Article
em En
| MEDLINE
| ID: mdl-26780929
ABSTRACT
MicroRNA-497 (miR-497) has been reported to be downregulated in certain types of cancer, including breast, gastric, endometrial, colorectal and prostate cancer as well as hepatocellular and nasopharyngeal carcinoma. The present study aimed to investigate the underlying mechanism of the tumor suppressor function of miR497 in prostate cancer. Following transfection with miR497, the DU145 and PC3 prostate cancer cell lines were subjected to Transwell migration and invasion assays, western blot analysis and a luciferase assay. It was revealed that miRNA497 inhibited the migration and invasion of prostate cancer cells. In addition, is was indicated that miRNA497 directly targets hepatomaderived growth factor (HDGF) in prostate cancer cells. These results suggested that restoration of miR497 and the resulting downregulation of HDFG may represent a promising therapeutic strategy for prostate cancer.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Próstata
/
Movimento Celular
/
Peptídeos e Proteínas de Sinalização Intercelular
/
MicroRNAs
Limite:
Humans
/
Male
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article